Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
David J PriceWilliam HenleyJosé Eduardo Delfini CançadoLeonardo M FabbriHuib A M KerstjensAlberto PapiNicholas RocheElif ŞenDave SinghClaus F VogelmeierElena NudoVictoria CarterDerek SkinnerRebecca K VellaJoan B SorianoMaxim KotsGeorge GeorgesPublished in: Pragmatic and observational research (2024)
Risk of pneumonia when using ICS for the management of COPD reported in several randomised controlled trials may not be relevant with ef-BDP in a diverse real-world clinical population.